You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Anticoagulants

Showing 26 - 50 of 1,435
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non-Valvular Atrial Fibrillation Patients Using Oral

Completed
  • Atrial Fibrillation
  • (no location specified)
May 4, 2022

Register for New Oral Anticoagulants

Recruiting
  • Anticoagulation Treatment
    • Dresden, Germany
      Universitätsklinikum Dresden on behalf of GWT-TUD GmbH
    Mar 15, 2022

    Acute Coronary Syndrome Trial (Rivaroxaban 2.5 Mg Oral Tablet, Clopidogrel tablet, Aspirin tablet)

    Not yet recruiting
    • Acute Coronary Syndrome
    • Rivaroxaban 2.5 Mg Oral Tablet
    • +2 more
    • (no location specified)
    Oct 5, 2022

    Mild Head Injury, Antiplatelets, and Anticoagulants

    Completed
    • Craniocerebral Trauma
    • Cerebral Hemorrhage
    • direct anticoagulant
    • +2 more
    • Roma, Rm, Italy
      Fondazione Policlinico Universitario Agostino Gemelli - IRCCS
    Mar 29, 2022

    Hemodialysis Complication, Anticoagulants Trial (anticoagulation dosing)

    Not yet recruiting
    • Hemodialysis Complication
    • Anticoagulants
    • anticoagulation dosing
    • (no location specified)
    Nov 17, 2023

    Caudal Block & Hip Fracture Surgery in Anticoagulated Patient

    Recruiting
    • Hip Fractures
    • Anticoagulants and Bleeding Disorders
      • Surrey, British Columbia, Canada
        Salem Anaesthesia Pain Clinic
      Jul 13, 2023

      How Clinicians Manage Their Patients Who May Need Antithrombotic

      Not yet recruiting
      • Antithrombotic Care
      • +5 more
        • (no location specified)
        Jun 27, 2023

        Thrombus of Left Ventricle Trial in Bern

        Recruiting
        • Thrombus of Left Ventricle
          • Bern, Switzerland
            Department of Cardiology, University Hospital Bern
          May 17, 2022

          Acute DVT of Lower Extremity Trial (New oral anticoagulant (rivaroxaban) and Marevan (warfarin))

          Not yet recruiting
          • Acute DVT of Lower Extremity
          • New oral anticoagulant (rivaroxaban) and Marevan (warfarin)
          • (no location specified)
          Nov 21, 2023

          Anticoagulation Length of ThErapy and Risk of New Adverse evenTs

          Completed
          • Venous Thromboembolism
          • Anticoagulants and Bleeding Disorders
          • Oral Anticoagulant
          • Oakland, California
          • +1 more
          Oct 31, 2022

          Atrial Fibrillation, Recurrent Venous Thromboembolism Trial in Barcelona (dabigatran, rivaroxaban, apixaban or edoxaban)

          Recruiting
          • Atrial Fibrillation
          • Recurrent Venous Thromboembolism
          • dabigatran, rivaroxaban, apixaban or edoxaban
          • Barcelona, Catalonia, Spain
            Hospital de la Santa Creu i Sant Pau
          Apr 27, 2022

          Atrial Fibrillation, Stroke Trial in Edmonton (Anticoagulants)

          Active, not recruiting
          • Atrial Fibrillation
          • Stroke
          • Anticoagulants
          • Edmonton, Alberta, Canada
            University of Alberta
          Aug 8, 2022

          Different Anticoagulants in Thromboembolic Antiphospholipid

          Recruiting
          • Antiphospholipid Syndrome
          • +3 more
            • Frankfurt, Hessen, Germany
              Edelgard Lindhoff-Last
            Jan 18, 2022

            Direct Oral Anticoagulants for Treatment of Cerebral Venous

            Recruiting
            • Cerebral Venous Thrombosis
            • Oral anticoagulant
            • Amsterdam, Noord-Holland, Netherlands
              Jonathan Coutinho
            Feb 11, 2022

            Exploratory Drug Interaction Study Between SMIs and DOACs

            Recruiting
            • Solid Tumor
            • Cancer, Lung
              • Nijmegen, Gelderland, Netherlands
              • +1 more
              Feb 7, 2023

              Oral Anticoagulants Among Obese Non-Valvular A-Fib In VA

              Completed
              Has Results
              • Atrial Fibrillation
              • +2 more
              • New York, New York
                Pfizer
              Oct 28, 2021

              Self-care and Self-efficacy Scale in Oral Anticoagulation

              Not yet recruiting
              • Anticoagulants
              • +2 more
              • Self-assess and reporting self-care self-efficacy levels
              • (no location specified)
              Apr 19, 2023

              Oral Anticoagulants in Italian Elderly Non-Valvular Atrial

              Recruiting
              • Non-Valvular Atrial Fibrillation (NVAF)
                • Milano, MI, Italy
                  Ecol Studio SpA
                Jan 31, 2022

                CytoSorb® Filter to Remove Anticoagulants From Circulation

                Recruiting
                • Aortic Dissection
                • Factor X Inhibition
                  • Oslo, Norway
                    Oslo University Hospital
                  Jan 31, 2022

                  Atrial Fibrillation, Atrial Flutter, Adherence, Medication Trial in Worcester, Ann Arbor (Storytelling Intervention)

                  Not yet recruiting
                  • Atrial Fibrillation
                  • +6 more
                  • Storytelling Intervention
                  • Worcester, Massachusetts
                  • +1 more
                  Aug 11, 2023

                  Oral Anticoagulant, Adherence Trial in Amiens (questionary)

                  Recruiting
                  • Oral Anticoagulant
                  • Adherence
                  • questionary
                  • Amiens, France
                    CHU Amiens
                  Jul 27, 2022

                  Italian Anticoagulated Population

                  Recruiting
                  • Anticoagulants
                  • Name not applicable
                  • San Donato Milanese, MI, Italy
                    IRCCS Policlinico San Donato
                  Feb 2, 2023

                  Direct Oral Anticoagulants (DOACs) in Hypercoagulable States

                  Completed
                  • Hypercoagulable States
                  • Observational
                  • Dallas, Texas
                    Methodist Dallas Medical Center
                  Dec 9, 2021

                  Healthy Trial (Tegoprazan 50mg, Edoxaban 60mg, Apixaban 5mg)

                  Not yet recruiting
                  • Healthy
                  • Tegoprazan 50mg
                  • +3 more
                  • (no location specified)
                  Feb 2, 2023

                  Non-paroxysmal Atrial Fibrillation Trial in Beijing (Thoracoscopic LAA clipping, Novel oral anticoagulant)

                  Not yet recruiting
                  • Non-paroxysmal Atrial Fibrillation
                  • Thoracoscopic LAA clipping
                  • Novel oral anticoagulant
                  • Beijing, Beijing, China
                    China National Center for Cardiovascular Diseases
                  Aug 31, 2023